P1–349: A phase II double‐blind, placebo‐controlled randomized trial of an escalating dose of thalidomide in the treatment of Alzheimer's disease: Baseline characteristics. (1st July 2013)

Record Type:: Journal Article
Title:: P1–349: A phase II double‐blind, placebo‐controlled randomized trial of an escalating dose of thalidomide in the treatment of Alzheimer's disease: Baseline characteristics. (1st July 2013)
Main Title:: P1–349: A phase II double‐blind, placebo‐controlled randomized trial of an escalating dose of thalidomide in the treatment of Alzheimer's disease: Baseline characteristics
Authors:: Sabbagh, Marwan
Decourt, Boris
Liebsack, Carolyn
Sirrel, Sherye
Walker, Aaron
Gonzales, Amanda
Macias, Mimi
Jacobson, Sandra
Malek‐Ahmadi, Michael
Belden, Christine
Abstract:
Is Part Of:: Alzheimer's & dementia. Volume 9:Supplement 4S(2013)Part 7
Journal:: Alzheimer's & dementia
Issue:: Volume 9:Supplement 4S(2013)Part 7
Issue Display:: Volume 9, Issue 4, Part 7 (2013)
Year:: 2013
Volume:: 9
Issue:: 4
Part:: 7
Issue Sort Value:: 2013-0009-0004-0007
Page Start:: P285
Page End:: P285
Publication Date:: 2013-07-01
Subjects:: Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83
Journal URLs:: http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.jalz.2013.05.575 ↗
Languages:: English
ISSNs:: 1552-5260
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 13305.xml